939426-84-3

Basic information

• Product Name: (3-Hydroxy-cyclopentyl)-carbamic acid benzyl ester
• Synonyms: (3-Hydroxy-cyclopentyl)-carbamic acid benzyl ester;Benzyl (3-hydroxycyclopentyl)carbamate;3-hydroxycyclopentylcarbamate;3-Cbz-amino-cyclopentanol
• CAS NO: 939426-84-3
• Molecular Formula: C13H17NO3
• Molecular Weight: 235.29
• Mol File: 939426-84-3.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: (3-Hydroxy-cyclopentyl)-carbamic acid benzyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (3-Hydroxy-cyclopentyl)-carbamic acid benzyl ester(939426-84-3)
• EPA Substance Registry System: (3-Hydroxy-cyclopentyl)-carbamic acid benzyl ester(939426-84-3)

Safety Data

• Hazardous Substances Data: 939426-84-3(Hazardous Substances Data)

Usage

General Description

"(3-Hydroxy-cyclopentyl)-carbamic acid benzyl ester" is a chemical compound often used in the research fields of sciences. The molecular formula of the compound is C14H18O4. It falls under the class of cyclopentanols, which are compounds containing a cyclopentane ring which bears an alcohol group. From a structural perspective, it contains a benzyl ester moiety derived from carbamic acid and a hydroxy cyclopentyl ring. However, the specific properties and potential applications vary and can be determined based on it being a derivative of carbamic acid. As with all chemical substances, it is important to handle it appropriately to prevent any potential hazards or risks.

Upstream product

• 124555-33-5 (trans)-3-aminocyclopentan-1-ol hydrochloride 
• 501-53-1 benzyl chloroformate 
• 167298-58-0 (±)-trans-(3-hydroxy-cyclopentyl)amine 
• 946593-67-5 (1S,3S)-3-aminocyclopentan-1-ol 
• 75315-63-8 N-(benzyloxycarbonyl)succinimide 
• 1184919-69-4 rac-3-aminocyclopentanol hydrochloride 

Downstream Products

• 932706-26-8 benzyl [(1S,3R)-3-fluorocyclopentyl]carbamate 
• 939525-61-8 3,3-difluorocyclopentanamine 

Relevant articles and documents

HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS

Heterocyclic compounds as CDK4 or CDK6 or other CDK inhibitors are provided. The compounds may find use as therapeutic agents for the treatment of diseases and may find particular use in oncology.

TETRACYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS

The present invention relates to Tetracyclic Heterocycle Compounds of Formula (I) and pharmaceutically acceptable salts or prodrug thereof, wherein n, X, Y, Z, R1, R2, and R3 are as defined herein. The present invention also relates to compositions comprising at least one Tetracyclic Heterocycle Compound, and methods of using the Tetracyclic Heterocycle Compounds for treating or preventing HIV infection in a subject.

4-CYCLOALKYLAMINOPYRAZOLO PYRIMIDINE NMDA/NR2B ANTAGONISTS

Compounds represented by Formula (I): or pharmaceutically acceptable salts thereof, are effective as NMDA/NR2B antagonists useful for treating neurological conditions such as, for example, pain, Parkinson's disease, Alzheimer's disease, epilepsy, depression, anxiety, ischemic brain injury including stroke, and other conditions.